Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Lometrexol, an antipurine <a href="/target/Antifolate" style="display: inline; color: #c13a36">Antifolate</a>, can inhibit the activity of glycinamide ribonucleotide formyltransferase (GARFT) but do not induce detectable levels of <a href="/target/DNA" style="display: inline; color: #c13a36">DNA</a> strand breaks. Lometrexol can further inhibit de novo purine synthesis, causing abnormal cell proliferation and <a href="/pathway/Apoptosis" style="display: inline; color: #c13a36">Apoptosis</a>, even <a href="/target/cell_cycle_arrest" style="display: inline; color: #c13a36">cell cycle arrest</a>. Lometrexol has anticancer activity. Lometrexol also is a potent human Serine hydroxymethyltransferase1/2 (hSHMT1/2) inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 253.00 | |
5 mg | In stock | $ 752.00 | |
10 mg | In stock | $ 1,261.00 | |
25 mg | In stock | $ 1,861.00 | |
50 mg | In stock | $ 2,788.00 | |
100 mg | In stock | $ 4,183.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 827.00 |
Description | Lometrexol, an antipurine Antifolate, can inhibit the activity of glycinamide ribonucleotide formyltransferase (GARFT) but do not induce detectable levels of DNA strand breaks. Lometrexol can further inhibit de novo purine synthesis, causing abnormal cell proliferation and Apoptosis, even cell cycle arrest. Lometrexol has anticancer activity. Lometrexol also is a potent human Serine hydroxymethyltransferase1/2 (hSHMT1/2) inhibitor. |
In vitro | Lometrexol binds tightly to GART, resulting in a rapid and prolonged depletion of intracellular purine ribonucleotides. Lometrexol (1-30 μM; 2-10 hours) induces rapid and complete growth inhibition in L1210 cells. Lometrexol (1 μM; 2-24 hours) induces cell cycle arrest in murine leukemia L1210 cells[3]. |
In vivo | Lometrexol (DDATHF; i.p.; 15-60 mg/kg; on gestation day 7.5) induces neural tube defects (NTDs) by disturbing purine metabolism and increases the rate of embryonic resorption and growth retardation in a dose-dependent manner. Lometrexol (i.p.; 40 mg/kg; on gestation day 7.5) decreases glycinamide ribonucleotide formyl transferase (GARFT) activity and Changes of ATP, GTP, dATP and dGTP levels[1]. Lometrexol (i.p.; 40 mg/kg; on gestation day 7.5) induces abnormal proliferation and apoptosis exist in neural tube defects (NTDs)[1]. |
Synonyms | DDATHF, LY 264618 |
Molecular Weight | 443.45 |
Formula | C21H25N5O6 |
CAS No. | 106400-81-1 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 36mg/mL (81.2mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lometrexol 106400-81-1 Cell Cycle/Checkpoint DNA Damage/DNA Repair Metabolism DHFR DDATHF LY 264618 Inhibitor inhibitor inhibit